Search - tctmd.com

Displaying 221 - 240 of 504

Sort: Relevancy | Date

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

News Industry News

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

May 14, 2019

News Industry News

Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias

April 30, 2019

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

Patients Stop CVD Medications When Their Pharmacy Closes

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

News Daily News

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

April 15, 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

March 25, 2019

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

News Conference News EHRA 2019

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

March 20, 2019

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

March 14, 2019

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

News Daily News

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

February 12, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

January 08, 2019

Top News in Clinical Cardiology: 2018

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

Barbershop Intervention for High BP Has Lasting Effects

News Daily News

Barbershop Intervention for High BP Has Lasting Effects

December 19, 2018

CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden

News Conference News WCC 2018

CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden

December 06, 2018

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

November 26, 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.